The pharmacokinetics of trinitroglycerin and its metabolites in patients with chronic stable angina

British Journal of Clinical Pharmacology

Volumn 50, Issue 4, 2000, Pages 373-376

  Hashimoto, S ^a   Yamauchi, E ^a   Kobayashi, A ^a   Shigemi, K ^a   Tsuruta, H ^a   Yamashita, T ^a   Tanaka, Y ^a  

^a NONE   (Japan)

Author keywords

Plasma concentration; Transdermal tape system; Trinitroglycerin

Indexed keywords

GLYCEROL 1 NITRATE; GLYCEROL 1,2 DINITRATE; GLYCEROL 1,3 DINITRATE; GLYCEROL 2 NITRATE; GLYCERYL TRINITRATE;

ADULT; AGED; ANGINA PECTORIS; ARTICLE; CHRONIC DISEASE; CLINICAL ARTICLE; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG EFFECT; DRUG SCREENING; FEMALE; HUMAN; MALE; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; ANGINA PECTORIS; CHRONIC DISEASE; FEMALE; HUMAN; MALE; MIDDLE AGE; NITROGLYCERIN; VASODILATOR AGENTS;

EID: 0033775070     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2125.2000.00263.x     Document Type: Article

References (3)

1. Improved gas chromatographic assay for the simultaneous determination of nitroglycerin and its mono- and dinitrate metabolites
2. Intermittent or continuous transdermal nitroglycerin: Still an issue, or is the case closed?
3. Effects of intermittent transdermal nitroglycerin on occurrence of ischemia after patch removal: Results of the second transdermal intermittent dosing evaluation study (TIDES-II)